Broad Discovery Series: The story behind a new therapy for lung cancer patients
By
Broad Institute of MIT and Harvard
Free
Heidi Greulich and Matthew Meyerson will describe the 20-year history of sevabertinib, a new lung cancer drug that blocks both EGFR and the related HER2 protein.
Sign-up Information
- Ages: Adults.
No application or registration needed.
Cost
This Event is free!
Location
- Both in-person and virtual (online or over the phone).
415 Main Street
Cambridge, MA 02142
United States
Neighborhood
Dates and Times
Tuesday, February 24 6PM – 8PM
Free
Share with your friends!
Is there anything wrong or outdated? Please let Find It Cambridge know!
Last updated January 27, 2026.